Morningstar

Cencora Inc COR

Morningstar Rating
Unlock
Stock XNYS Rating as of
$307.90 −0.09 (0.03%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Pricing Headwinds and Industry Trends Cut Into Cencora's 2026 Sales, but Fundamentals Remain Strong

Keonhee Kim

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With roughly $300 billion in annual US healthcare distribution sales, Cencora accounts for about a third of the domestic drug distribution market. Its two close competitors are Cardinal Health and McKesson, and the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the US market.

Read Full Report

Price vs Fair Value

View History
COR is trading at a LOCK|>&st^$l premium.
Price
$307.90
Fair Value
LOCK|j@
Uncertainty
LOCK|S#x<
1-Star Price
LOCK|$.Y%
5-Star Price
p<P
Economic Moat
LOCK|Q?$#
Capital Allocation
LOCK|@PdL&#j

Bulls Say, Bears Say

Bulls

Cencora distributes pharmaceutical products to nearly one-third of the industry, leading to substantial negotiation leverage with drug manufacturers.

Bears

Reimbursement pressures on pharmacy and provider customers have led to an emphasis on cost containment, pressuring Cencora's profitability.

Show More

Articles & Videos

Trading Information

Previous Close Price
$307.99
Day Range
$306.41–313.90
52-Week Range
$244.82–377.54
Bid/Ask
$305.60 / $307.90
Shares Outstanding
194.56M
Market Cap
$59.91B
Volume/Avg
2M / 2M

Key Statistics

Price/Earnings (Normalized)
18.47
Price/Sales
0.18
Dividend Yield (Trailing)
0.76%
Dividend Yield (Forward)
0.78%
Total Yield
0.76%

Company Profile

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Mid Core
Total Number of Employees
51,000
Website
https://www.cencora.com

Competitors

Valuation

View More
Metric
COR
HCA
MCK
Price/Earnings (Normalized)
 18.4712.8221.49
Price/Book Value
 17.63——
Price/Sales
 0.181.140.26
Price/Cash Flow
 15.987.0716.81
Price/Earnings
COR
HCA
MCK

Financial Strength

Metric
COR
HCA
MCK
Quick Ratio
 0.480.640.48
Current Ratio
 0.950.830.85
Interest Coverage
 8.185.2925.38
Quick Ratio
COR
HCA
MCK

Profitability

Metric
COR
HCA
MCK
Return on Assets (Normalized)
 5.17%13.39%5.96%
Return on Equity (Normalized)
 201.23%——
Return on Invested Capital (Normalized)
 38.43%21.68%60.93%
Return on Assets
COR
HCA
MCK

Medical Distribution Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
McKesson Corp
MCK
LOCK|Y#jKN^mLOCK|sDWR$99B
 Cardinal Health Inc
CAH
LOCK|PPY>KCRLOCK|$Dh^$54B
 Sigma Healthcare Ltd
SIGGF
—LOCK|@@Yz$24B
 Henry Schein Inc
HSIC
LOCK|Mq$^SGLOCK|L<m^#$10B
 Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
—LOCK|@@j$8B
 Sinopharm Group Co Ltd ADR
SHTDY
—LOCK|l^D$7B
 Sinopharm Group Co Ltd
SHTDF
—LOCK|&v$7B
 Medipal Holdings Corp ADR
MAHLY
—LOCK|?%$4B
 Medipal Holdings Corp
MEPDF
—LOCK|Xcs$4B

Sponsor Center